The "DEAF1 Gene Mental Retardation Autosomal Dominant Type 24 Genetic Test" is a specialized diagnostic assessment offered by DNA Labs UAE, aimed at detecting mutations in the DEAF1 gene, which are associated with Autosomal Dominant Mental Retardation Type 24. This condition, a form of intellectual disability, is inherited in an autosomal dominant pattern, meaning a mutation in just one of the two copies of the gene in each cell is sufficient to cause the disorder. Symptoms can vary but often include developmental delays, learning disabilities, and sometimes physical abnormalities.
The test is crucial for families with a history of this condition, as it can provide a definitive diagnosis, informing medical management and support strategies for affected individuals. Additionally, it can be a vital tool for prospective parents concerned about passing the condition to their offspring, offering them the opportunity to make informed decisions about family planning.
DNA Labs UAE conducts this test with precision and care, ensuring confidentiality and support throughout the process. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the DEAF1 gene. This investment can provide invaluable insights for affected families, guiding them towards appropriate interventions and support services to improve quality of life for individuals with Autosomal Dominant Mental Retardation Type 24.
The AHDC1 gene is associated with Mental Retardation, Autosomal Dominant Type 25 (MRD25), a genetic disorder characterized by intellectual disability and often other neurological or physical abnormalities. The AHDC1 gene plays a crucial role in brain development, and mutations in this gene can lead to various developmental delays and cognitive impairments.
To diagnose this condition, a genetic test targeting the AHDC1 gene can be performed. This test is crucial for understanding the genetic basis of the intellectual disability in affected individuals and can assist in managing and planning for the needs of the individual.
In the UAE, DNA Labs UAE offers this specific genetic test. The cost of the AHDC1 gene test is 4400 AED. Conducting this test can provide families with vital information regarding the condition, potential interventions, and the likelihood of passing the mutation to future generations. It's a critical step towards personalized care and management for individuals with MRD25.
The SOX11 Gene Mental Retardation Autosomal Dominant Type 27 Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the SOX11 gene that are associated with Autosomal Dominant Non-Syndromic Intellectual Disability (ADNSID) Type 27. This condition, characterized by varying degrees of cognitive impairment and sometimes accompanied by other neurological or physical abnormalities, is inherited in an autosomal dominant manner, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder.
The SOX11 gene plays a crucial role in the development of the nervous system, and mutations in this gene can disrupt normal brain development, leading to intellectual disability. The test involves analyzing the patient's DNA, extracted from a blood sample, to detect mutations in the SOX11 gene that are known to cause the condition.
The cost of the SOX11 Gene Mental Retardation Autosomal Dominant Type 27 Genetic Test at DNA Labs UAE is 4400 AED. The test is a valuable resource for families seeking answers about intellectual disability and related conditions, providing essential information for diagnosis, management, and genetic counseling. By confirming a diagnosis, the test can help tailor educational and developmental support to the individual's needs and offer insights into the risk of passing the condition on to future generations.
The "ADNP Gene Mental Retardation Autosomal Dominant Type 28 Genetic Test" is a specialized diagnostic procedure aimed at identifying mutations in the ADNP gene, which have been linked to a rare form of autosomal dominant intellectual disability, known as Helsmoortel-Van der Aa syndrome. This condition is characterized by a wide range of symptoms including developmental delays, intellectual disability, speech impairments, and sometimes autism spectrum disorders. The test is crucial for families seeking a definitive diagnosis to understand the genetic basis of the condition, enabling targeted interventions and support.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the test provides a comprehensive analysis of the ADNP gene to detect any anomalies that might be responsible for the condition. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the gene. Results from this test can offer invaluable insights for affected individuals and their families, guiding them towards appropriate care and management strategies.
The CDH15 gene is associated with a condition known as Mental Retardation, Autosomal Dominant Type 3 (MRD3), a disorder characterized by intellectual disabilities and possibly other neurological or physical abnormalities. The CDH15 gene plays a critical role in the development and function of the brain, influencing cell-cell adhesion processes which are essential for proper neural development.
A genetic test for MRD3 linked to the CDH15 gene can provide crucial information for individuals suspected of having this condition or families with a history of intellectual disabilities. This test involves analyzing the DNA to identify mutations in the CDH15 gene that are responsible for the disorder. Early diagnosis through genetic testing can aid in managing the condition more effectively, allowing for tailored educational programs, therapy, and support to improve the quality of life for affected individuals.
In the UAE, DNA Labs offers a comprehensive genetic test for the CDH15 gene to diagnose Mental Retardation, Autosomal Dominant Type 3. The test cost is set at 4400 AED, reflecting the specialized nature of the analysis and the advanced technology used to detect mutations in the gene accurately. Conducted in a state-of-the-art facility, the test provides a reliable diagnosis, enabling healthcare professionals and families to take informed steps towards managing the condition.
The PURA gene mental retardation autosomal dominant type 31 genetic test is a specialized diagnostic procedure designed to identify mutations in the PURA gene, which have been associated with a rare form of intellectual disability known as mental retardation, autosomal dominant type 31. This condition is characterized by developmental delays, intellectual challenges, and in some cases, physical abnormalities and neurological issues. The test is crucial for early diagnosis, which can significantly aid in the management and treatment of the condition, potentially improving the quality of life for those affected.
Performed at DNA Labs UAE, a leading genetic testing facility, this test offers a comprehensive analysis of the PURA gene to detect any abnormalities that may indicate the presence of the disorder. The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise required to conduct such a specialized genetic analysis. By choosing DNA Labs UAE for this test, patients and healthcare providers can expect high-quality services, accurate results, and the support needed to understand and manage the implications of the findings.
The "MBD5 Gene Mental Retardation Autosomal Dominant Type 1 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the MBD5 gene, which are linked to mental retardation autosomal dominant type 1 (MRD1). This condition is characterized by various degrees of intellectual disability, potential developmental delays, and sometimes accompanying physical or neurological symptoms. The test is crucial for families seeking answers about developmental concerns, as it can confirm a diagnosis, inform clinical management, and aid in family planning.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test involves analyzing the patient's DNA sample to look for specific genetic alterations in the MBD5 gene that are known to cause MRD1. The process is meticulous, ensuring high accuracy and reliability in the results.
The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. For families affected by or at risk of MRD1, this test offers invaluable insights into the genetic underpinnings of the condition, enabling informed decisions about care and support.
The EPB41L1 gene plays a crucial role in cognitive development and brain function. Mutations in this gene have been linked to Mental Retardation, Autosomal Dominant Type 11, a condition characterized by intellectual disabilities and possibly other neurological or physical abnormalities. To diagnose this condition, a genetic test targeting the EPB41L1 gene can be conducted.
At DNA Labs UAE, individuals suspected of having Autosomal Dominant Type 11 Mental Retardation can undergo a specialized genetic test to detect mutations in the EPB41L1 gene. This test is a crucial step in confirming the diagnosis, which can then guide appropriate management and intervention strategies for the affected individuals and their families.
The cost of the EPB41L1 gene test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis of the gene to identify any mutations that may be responsible for the condition. Given the importance of accurate diagnosis for effective treatment and support, this test represents a valuable tool for individuals and families seeking answers about developmental and cognitive concerns.
The EFTUD2 Gene Mandibulofacial Dysostosis with Microcephaly Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the EFTUD2 gene, which are linked to the rare genetic disorder known as Mandibulofacial Dysostosis with Microcephaly (MFDM). This condition is characterized by distinctive craniofacial features, microcephaly, and often other physical and developmental abnormalities. The test is crucial for accurate diagnosis, guiding treatment options, and providing essential information for genetic counseling.
Performed through a detailed analysis of the patient's DNA, this test seeks to detect specific genetic alterations in the EFTUD2 gene that are responsible for the development of MFDM. Early diagnosis through genetic testing can significantly benefit affected individuals and their families by enabling timely intervention and support services.
The cost of the EFTUD2 Gene Mandibulofacial Dysostosis with Microcephaly Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive process of collecting a DNA sample, usually through a blood draw or cheek swab, conducting the genetic analysis, and providing a detailed report on the findings. The test is conducted with high precision and confidentiality, ensuring patients receive accurate and actionable results.
The PIEZO2 Gene Marden-Walker Syndrome Genetic Test is a specialized diagnostic tool designed to identify mutations in the PIEZO2 gene, which are associated with Marden-Walker Syndrome. Marden-Walker Syndrome is a rare congenital disorder characterized by multiple skeletal abnormalities, including a fixed facial expression, joint contractures, and a decrease in muscle tone. This condition is believed to be largely caused by mutations in the PIEZO2 gene, which plays a crucial role in the body's mechanical responses to stimuli.
The test is conducted at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab to detect any mutations in the PIEZO2 gene. This test is crucial for families seeking a definitive diagnosis of Marden-Walker Syndrome, as it can guide treatment options and help in understanding the prognosis.
The cost of the PIEZO2 Gene Marden-Walker Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the PIEZO2 gene. While the cost may be significant, the test offers invaluable insights for affected individuals and their families, aiding in the management and understanding of Marden-Walker Syndrome.
